Acquisition Completed Sponsor buyer Sponsor exit
Metagenics acquisition of Symprove
Announced 22 Jan 2026
Advisers
Metagenics
Acquirer
- Financial adviser
- Spayne Lindsay & Co.
- Legal adviser
- Financial due diligence
- Target
- Symprove
- Acquirer
- Metagenics
- Sponsor
- Gryphon Investors
- Seller
- bd-capital
- Target based in
- United Kingdom
- Buyer based in
- United States
- Completed
- 22 Jan 2026
- Sector
- Supplements
- Tags
- Supplements, Consumer Health
In the league tables
- M&A financial advisers, 2026 to date Jefferies #14 · Greenhill #46
- M&A financial advisers, completed, 2026 to date Jefferies #22 · Greenhill #25
- M&A legal advisers, 2026 to date Kirkland & Ellis #1 · Stephenson Harwood #237
- M&A legal advisers, completed, 2026 to date Kirkland & Ellis #3 · Stephenson Harwood #140
Similar deals
- Yellow Wood Partners acquisition of Holistic Health platform Sep 2026 · US$1bn · Supplements
- Kirin Holdings acquisition of Jamieson Wellness Aug 2026 · US$1.8bn · Supplements
- The Procter & Gamble Company acquisition of Thorne Aug 2026 · US$3.8bn · Supplements
- Bain Capital acquisition of Vitabiotics Jul 2026 · Supplements
- Avista Healthcare Partners acquisition of sanotact Group May 2026 · Supplements
Sources
- Jan 2026 Kirkland Advises Metagenics on Acquisition of Symprove kirkland.com
- 22 Jan 2026 Press release (PR Newswire), Gryphon Investors-Backed Metagenics Acquires Probiotic Brand Symprove prnewswire.com





